Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Appellate Court Decision Affirms the Strength of Guidant's Coronary Stent Patents.


Business Editors

INDIANAPOLIS--(BW HealthWire)--Aug. 10, 2001

Guidant Corporation (NYSE NYSE

See: New York Stock Exchange
:GDT GDT Global Descriptor Table
GDT Geographic Data Technology Inc.
GDT Gas Discharge Tube (energy, electrotechinical and electronics)
GDT Getting Things Done
GDT Geometric Dimensioning & Tolerancing
GDT Ground Data Terminal
)(PCX (1) A bitmapped graphics file format that handles monochrome, 2-bit, 4-bit, 8-bit and 24-bit color and uses RLE to achieve compression ratios of approximately 1.1:1 to 1.5:1. Images with large blocks of solid colors compress best under the RLE method. See PC Paintbrush. :GDT) today stated that a recent U.S. Court of Appeals ruling on a coronary stent patent infringement suit affirms the strength of specific Guidant coronary stent patents.

"We are very gratified grat·i·fy  
tr.v. grat·i·fied, grat·i·fy·ing, grat·i·fies
1. To please or satisfy: His achievement gratified his father. See Synonyms at please.

2.
 by the court's decision," said Ronald W. Dollens, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Guidant Corporation. "This ruling confirms the fundamental importance of this particular set of patents that utilize stent technology to treat vascular disease."

The patent infringement suit was between Guidant and Boston Scientific. Last year, Guidant and Boston Scientific signed a comprehensive settlement agreement covering technology involved in various matters in dispute between the two companies. This agreement included a restricted license to these patents.

Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to 7 million cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of 10,000 employees, develops, manufactures and markets a broad array of products and services that enable less invasive care for some of life's most threatening medical conditions. For more information visit www.guidant.com.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 10, 2001
Words:183
Previous Article:Acorn Products Reports Strong Second Quarter Net Income Improvement and Announces Credit Facility Agreement.
Next Article:John V. Tunney Named Foamex Vice Chairman.
Topics:



Related Articles
Guidant Wins the Medtronic Wiktor Stent Patent Infringement Case.
Guidant Announces FDA Approval of its MULTI-LINK TETRA Coronary Stent System.
Guidant Announces FDA Approval of its MULTI-LINK ULTRA Coronary Stent System for Large Coronary Arteries.
GUIDANT'S INTRAVASCULAR RADIOTHERAPY MEETS EUROPEAN GOAL.
Guidant Poised for U.S. Launch of Newest Coronary Stent System; Company Receives FDA Approval of MULTI-LINK PENTA.
Guidant Unveils Latest Coronary Stent Technology in Europe; Company Launches MULTI-LINK PENTA Stent.
First Patients Treated with Guidant's Next Generation Coronary Stent; Latest Stent Constructed of New Material Designed to Enhance Performance.
Guidant Elaborates on its Distribution Agreement With COOK.
Guidant Announces Significant Progress in its Multiple Programs for Drug-Coated Stents; Guidant Completes ACTION Clinical Trial Enrollment for FDA...
Guidant's Market-Leading MULTI-LINK PENTA Stent Demonstrates Excellent Clinical Data; Six Month Follow-Up Study Shows 17.5 Percent Binary Restenosis...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles